Evidence map›Paper›PMID 36712563›Full record

ArticleBiological psychiatry global open science2023

Antidepressant Response and Stress Resilience Are Promoted by CART Peptides in GABAergic Neurons of the Anterior Cingulate Cortex.

Yuki Funayama, Haiyan Li, Erina Ishimori, Ayako Kawatake-Kuno, Hiromichi Inaba, Hirotaka Yamagata, Tomoe Seki, Shin Nakagawa, Yoshifumi Watanabe, Toshiya Murai and 2 more

Open access · goldAbstract read
In one paragraph

Article in Biological psychiatry global open science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Contribution of the Serotonin 5-HTNeuropsychopharmacology reports · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A New Insight into the Role of CART Peptide in Serotonergic Function and Anxiety.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Yuki FunayamaSK Project, Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Haiyan LiSK Project, Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Erina IshimoriSK Project, Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Ayako Kawatake-KunoSK Project, Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Hiromichi InabaSK Project, Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Hirotaka YamagataDivision of Neuropsychiatry, Department of Neuroscience, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
Tomoe SekiDivision of Neuropsychiatry, Department of Neuroscience, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
Shin NakagawaDivision of Neuropsychiatry, Department of Neuroscience, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
Yoshifumi WatanabeDivision of Neuropsychiatry, Department of Neuroscience, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
Toshiya MuraiSK Project, Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Naoya OishiSK Project, Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Shusaku UchidaSK Project, Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kyoto University · JPYamaguchi University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: A key challenge in the understanding and treatment of depression is identifying cell types and molecular mechanisms that mediate behavioral responses to antidepressant drugs. Because treatment responses in clinical depression are heterogeneous, it is crucial to examine treatment responders and nonresponders in preclinical studies. Methods: We used the large variance in behavioral responses to long-term treatment with multiple classes of antidepressant drugs in different inbred mouse strains and classified the mice into responders and nonresponders based on their response in the forced swim test. Medial prefrontal cortex tissues were subjected to RNA sequencing to identify molecules that are consistently associated across antidepressant responders. We developed and used virus-mediated gene transfer to induce the gene of interest in specific cell types and performed forced swim, sucrose preference, social interaction, and open field tests to investigate antidepressant-like and anxiety-like behaviors. Results: Conclusions: These data demonstrate that activation of CART peptide signaling in GABAergic neurons of the anterior cingulate cortex is a common molecular mechanism across antidepressant responders and that this pathway also drives stress resilience.

Indexed as

Anterior cingulate cortexAntidepressant responseDepressionGABAergic neuronsStress resilienceTranscriptome

Identifiers

PMID36712563
PMCPMC9874166
OpenAlexW4206083694

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.